Literature DB >> 12502982

Halogenated anesthetics reduce interleukin-1beta-induced cytokine secretion by rat alveolar type II cells in primary culture.

Olivier Giraud1, Serge Molliex, Corinne Rolland, Véronique Leçon-Malas, Jean-Marie Desmonts, Michel Aubier, Monique Dehoux.   

Abstract

BACKGROUND: Alveolar epithelial type II (AT II ) cells participate in the intraalveolar cytokine network by secreting cytokines and are widely exposed to volatile anesthetics during general anesthesia. The aim of the current study was to evaluate the effects of halothane, enflurane, and isoflurane on rat AT II cell cytokine secretions in AT II primary cell cultures.
METHODS: Alveolar epithelial type II primary cell cultures were obtained from adult rat lungs. AT II cells were stimulated by recombinant murine interleukin-1beta (rmIL-1beta) to mimic an inflammatory response, and immediately exposed for various duration to different concentration of halothane, enflurane, or isoflurane. Interleukin-6, macrophage inflammatory protein-2 (MIP-2), and monocyte chemoattractant protein-1 (MCP-1) protein concentrations were then measured in cell culture supernatants. Recombinant mIL-1beta-stimulated AT II cells exposed to air served as control.
RESULTS: Halothane, isoflurane, and enflurane (1 minimum alveolar concentration [MAC], 4 h) decreased rmIL-1beta-stimulated AT II cell secretions of interleukin-6, MIP-2, and MCP-1, but did not modify total protein secretion. Halothane exposure decreased rmIL-1beta-stimulated AT II cell secretions of interleukin-6, MIP-2, and MCP-1 in a dose- and time-dependent manner. Total protein concentrations remained unchanged except AT II 1.5 MAC of halothane, and no cytotoxic effect could be evidenced by lactate dehydrogenase release. These effects were transient as rmIL-1beta-stimulated AT II cell secretions of interleukin-6 and MIP-2 progressively reached control values between 4 and 24 h after the end of halothane exposure. However, MCP-1 inhibition persisted until 24 h. rmIL-1beta-induced MIP-2 and tumor necrosis factor-alpha mRNA expression were decreased by 36 and 24%, respectively, after halothane exposure.
CONCLUSIONS: The current study shows that exposure of rmIL-1beta-stimulated AT II cells to volatile anesthetics reversibly alters their cytokine secretion. Therefore, volatile anesthesia, by modulating pulmonary epithelial cell secretion of inflammatory cytokines, might affect the lung inflammatory response.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12502982     DOI: 10.1097/00000542-200301000-00015

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  11 in total

1.  Adverse effects of vapocoolant and topical anesthesia for tail biopsy of preweanling mice.

Authors:  Gillian C Braden; Angela K Brice; F Claire Hankenson
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-05       Impact factor: 1.232

2.  Effects of volatile vs. propofol-based intravenous anesthetics on the alveolar inflammatory responses to one-lung ventilation: a meta-analysis of randomized controlled trials.

Authors:  Bin Sun; Jinfeng Wang; Lulong Bo; Yan Zang; Haihui Gu; Jinbao Li; Baohua Qian
Journal:  J Anesth       Date:  2015-02-26       Impact factor: 2.078

Review 3.  The Impact of General Anesthesia on Redox Stability and Epigenetic Inflammation Pathways: Crosstalk on Perioperative Antioxidant Therapy.

Authors:  Stelian Adrian Ritiu; Alexandru Florin Rogobete; Dorel Sandesc; Ovidiu Horea Bedreag; Marius Papurica; Sonia Elena Popovici; Daiana Toma; Robert Iulian Ivascu; Raluca Velovan; Dragos Nicolae Garofil; Dan Corneci; Lavinia Melania Bratu; Elena Mihaela Pahontu; Adriana Pistol
Journal:  Cells       Date:  2022-06-09       Impact factor: 7.666

Review 4.  Immune Modulation by Volatile Anesthetics.

Authors:  Lindsay M Stollings; Li-Jie Jia; Pei Tang; Huanyu Dou; Binfeng Lu; Yan Xu
Journal:  Anesthesiology       Date:  2016-08       Impact factor: 7.892

5.  Continuous monitoring of inflammation biomarkers during simulated cardiopulmonary bypass using a microfluidic immunoassay device - a pilot study.

Authors:  Lawrence A Sasso; Kiana Aran; Yulong Guan; Akif Ündar; Jeffrey D Zahn
Journal:  Artif Organs       Date:  2013-01       Impact factor: 3.094

6.  Immunomodulatory Effects of Anesthetics during Thoracic Surgery.

Authors:  Khaled Mahmoud; Amany Ammar
Journal:  Anesthesiol Res Pract       Date:  2011-10-27

7.  Antiinflammatory effect of sevoflurane in open lung surgery with one-lung ventilation.

Authors:  Iztok Potočnik; Vesna Novak Janković; Maja Šostarič; Ales Jerin; Tomaž Štupnik; Milan Skitek; Jasmina Markovič-Božič; Tomislav Klokočovnik
Journal:  Croat Med J       Date:  2014-12       Impact factor: 1.351

Review 8.  Immunomodulatory effects of anesthetics in obese patients.

Authors:  Luciana Boavista Barros Heil; Pedro Leme Silva; Paolo Pelosi; Patricia Rieken Macedo Rocco
Journal:  World J Crit Care Med       Date:  2017-08-04

Review 9.  Effects of Anesthetics on Barrier Tissue Function.

Authors:  Fujing Wang; Yanhui Li; Changlei Cui; Zhaoping Xue; Haichun Ma
Journal:  J Immunol Res       Date:  2019-10-21       Impact factor: 4.818

10.  Isoflurane promotes phagocytosis of apoptotic neutrophils through AMPK-mediated ADAM17/Mer signaling.

Authors:  Xueke Du; Chunling Jiang; Yang Lv; Randal O Dull; You-Yang Zhao; David E Schwartz; Guochang Hu
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.